Anthem Biosciences Ltd Holds 20th AGM, Releases FY26 Annual Report

Anthem Biosciences Ltd announced its 20th Annual General Meeting (AGM) scheduled for July 22, 2026, to be held via Video Conferencing. The company has released its Annual Report for the Financial Year 2025-26, in compliance with SEBI Listing Regulations. The report details the company's strategic framework based on 'People, Performance, and Progress', highlighting investments in capabilities, operational excellence, and sustainable growth. Key financial highlights for FY 2025-26 include Revenue from Operations of ₹21,243 Mn, EBITDA of ₹9,896 Mn, PAT of ₹13,743 Mn, and Net Cash of ₹5,918 Mn. The report is available on the company's website.